Literature DB >> 20664400

Chorioamnionitis and cerebral palsy: a meta-analysis.

Jobe G Shatrov1, Samuel C M Birch, Lawrence T Lam, Julie A Quinlivan, Sarah McIntyre, George L Mendz.   

Abstract

OBJECTIVE: To examine the relationships between clinical or histological chorioamnionitis and cerebral palsy using a meta-analysis approach. DATA SOURCES: A systematic review of the literature appeared in PubMed between 2000 and 2009 was conducted using the search terms "cerebral palsy" and "infection," with broad-scope variations in terminology of "white matter damage," "periventricular leukomalacia," "cystic periventricular leukomalacia," "chorioamnionitis," "intrauterine infection," "intraventricular hemorrhage," "funisitis," "fetal inflammatory response," "early neonatal sepsis," "neurological impairment," "virus," "bacteria," "fungi," and "protozoa," with variations of suffixes (eg, "viral," "bacterial," "fungal," "protozoan," etc), and "urinary tract infection," "bacterial vaginosis," "bacteriuria," and "cytokines." The related key words "gestational age," "small for gestational age," "preterm," and "low birth weight" also were added to the search terms. Only studies published in English were included.
METHODS: Three hundred eight articles were retrieved and systematically reviewed independently by two authors. Application of four inclusion criteria led to 15 studies being considered for data abstraction. An exposure was considered relevant if it met the established criteria for clinical or histological chorioamnionitis. The outcome was a diagnosis of cerebral palsy in accordance with established criteria.
RESULTS: The data were abstracted onto standard forms, correlated according to eight characteristics, and tabulated. Twelve of the 15 studies contained information on the association between clinical chorioamnionitis and cerebral palsy, and eight studies included information on the association between histological chorioamnionitis and cerebral palsy. The results indicated that there were significant associations between clinical chorioamnionitis or histological chorioamnionitis and cerebral palsy, for clinical chorioamnionitis (chi1=13.91; P<.001) with a pooled odds ratio of 2.42 (95% confidence interval 1.52-3.84), and for histological chorioamnionitis (chi1=6.86; P=.009) with a pooled odds ratio of 1.83 (95% confidence interval, 1.17-2.89). The data suggested increased risks of 140% and 80% for neonates exposed to clinical chorioamnionitis or histological chorioamnionitis, respectively.
CONCLUSION: The significant association of clinical or histological chorioamnionitis with cerebral palsy suggested that clinical strategies to prevent or reduce chorioamnionitis would lead to a reduction in cerebral palsy. The culture techniques currently used to diagnose the presence of pathogenic microorganisms during pregnancy need to improve, both in their methodology and in the length of time they require.

Entities:  

Mesh:

Year:  2010        PMID: 20664400     DOI: 10.1097/AOG.0b013e3181e90046

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  82 in total

1.  Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants.

Authors:  T Michael O'Shea; Elizabeth N Allred; Karl C K Kuban; Olaf Dammann; Nigel Paneth; Raina Fichorova; Deborah Hirtz; Alan Leviton
Journal:  J Pediatr       Date:  2011-10-13       Impact factor: 4.406

2.  A mouse model of term chorioamnionitis: unraveling causes of adverse neurological outcomes.

Authors:  Irina Burd; Amy Brown; Juan M Gonzalez; Jinghua Chai; Michal A Elovitz
Journal:  Reprod Sci       Date:  2011-03-18       Impact factor: 3.060

Review 3.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 4.  Neurodiagnostic techniques in neonatal critical care.

Authors:  Taeun Chang; Adre du Plessis
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

5.  Trends in the prevalence of cerebral palsy among very preterm infants (<31 weeks' gestational age).

Authors:  Michael J Vincer; Alexander C Allen; Victoria M Allen; Thomas F Baskett; Colleen M O'Connell
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

6.  Chorioamnionitis-induced fetal gut injury is mediated by direct gut exposure of inflammatory mediators or by lung inflammation.

Authors:  Tim G A M Wolfs; Boris W Kramer; Geertje Thuijls; Matthew W Kemp; Masatoshi Saito; Monique G M Willems; Paranthaman Senthamarai-Kannan; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

Review 7.  Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children.

Authors:  Martha Scott Tomlinson; Kun Lu; Jill R Stewart; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Clin Microbiol Rev       Date:  2019-05-01       Impact factor: 26.132

Review 8.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

9.  Antibiotic Therapy for Premature Rupture of Membranes and Preterm Labor and Effect on Fetal Outcome.

Authors:  B Seelbach-Goebel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

10.  The association of cord serum cytokines with neurodevelopmental outcomes.

Authors:  Michael W Varner; Nicole E Marshall; Dwight J Rouse; Kathleen A Jablonski; Kenneth J Leveno; Uma M Reddy; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Fergal D Malone; Marshall Carpenter; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Donald J Dudley; Steve N Caritis
Journal:  Am J Perinatol       Date:  2014-06-17       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.